Skip to content

Three-dimensional Ultrasound E-imaging for Breast Cancer: A Multicenter Study

Three-dimensional Ultrasound E-imaging for Breast Cancer: A Multicenter Study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026556
Enrollment
Unknown
Registered
2019-10-13
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast tumor

Interventions

Gold Standard:pathology
elastography

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years; 2. The patient had undergone molybdenum target examination and had a report of molybdenum target examination; 3. Breast puncture biopsy or surgery (one month after SWE) is planned, and the exact pathological results can be obtained; or benign masses, with a clear follow-up history; 4. The target mass had not undergone invasive operations such as puncture and biopsy before image acquisition; 5. All lesions are required to be less than 40 mm in diameter because of the size limitation of sampling frame.

Exclusion criteria

Exclusion criteria: 1. Images or clinical data are incomplete; 2. Pure cystic nodules and calcified nodules; 3. insufficient follow-up time or missing follow-up; 4. Withdrawal for various reasons.

Design outcomes

Primary

MeasureTime frame
Emax;Emean;Emin;E Ratio;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactYulan Peng

West China Hospital, Sichuan University

yulanpeng@163.com+86 18980601606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026